Thalidomide as a potential treatment for scleromyxedema.
Caradonna
Stephanie
S
University of North Carolina, Chapel Hill, NC, USA.
Jacobe
Heidi
H
D000284:Administration, Oral; D000328:Adult; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017512:Lichenoid Eruptions / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D035002:Lower Extremity; D009230:Myxedema / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use*; D034941:Upper Extremity
D007166:Immunosuppressive Agents; D013792:Thalidomide